Quimi Daphne insider trades
Quimi Daphne has filed 22 Form 4s with the SEC that we hold, for FOLD (Chief Financial Officer), Amylyx Pharmaceuticals, Inc. (AMLX) (Director) and Century Therapeutics, Inc. (IPSC) (Director). Across all of them we count 3 purchases worth $17.1K and 5 sales worth $311.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 6,923 shares of FOLD worth $90.0K, dated 2023-01-18. The first filing on our record is dated 2022-01-04 and the latest 2026-06-12.
FOLD
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-17 | S, sale reported on Form 4 | 4,396 | $39.6K | 2022-06-21 |
| 2022-08-05 | S, sale reported on Form 4 | 5,798 | $69.6K | 2022-08-09 |
| 2022-09-01 | S, sale reported on Form 4 | 4,397 | $49.6K | 2022-09-06 |
| 2023-01-17 | S, sale reported on Form 4 | 5,000 | $62.5K | 2023-01-19 |
| 2023-01-18 | S, sale reported on Form 4 | 6,923 | $90.0K | 2023-01-19 |
Amylyx Pharmaceuticals, Inc. (AMLX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-05-14 | P, purchase reported on Form 4 | 2,750 | $5.2K | 2024-05-16 |
| 2024-05-15 | P, purchase reported on Form 4 | 2,250 | $4.3K | 2024-05-16 |
Century Therapeutics, Inc. (IPSC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-12 | P, purchase reported on Form 4 | 5,000 | $7.7K | 2024-09-16 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1543031) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms